For its part, Abecma made $89 million in the second quarter, up 36% on the previous quarter with the increase driven by "expanded capacity and vector supply," according to BMS.

Following MHRA approval of a clinical trial, a study on Nuwiq, a recombinant FVIII therapy for the treatment of haemophilia A, can proceed. Background Haemophilia A is an inherited bleeding ...

Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Provided by GlobeNewswire Jul 1, 2025, 12:00:00 AM ...

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Press Release Date 07-01-2025 ...

Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...

A batch of Omeprazole, a medication commonly used to treat conditions such as indigestion, has been recalled following a complaint. The Medicines and Healthcare products Regulatory Agency (MHRA ...

Sheffield, UK, July 1 2025 - Rinri Therapeutics, a world leading company focused on transforming sensorineural hearing loss (SNHL) with regenerative cell therapy, is pleased to announce the approval ...

The MHRA is urging people taking GLP-1 medicine who have been hospitalised due to acute pancreatitis to submit a report to its Yellow Card scheme. Upon receipt of a Yellow Card report, the MHRA ...

A batch of medication commonly used to treat conditions such as indigestion has been recalled after a complaint was made. The Medicines and Healthcare products Regulatory Agency (MHRA) announced ...